nodes	percent_of_prediction	percent_of_DWPC	metapath
Levonorgestrel—PGR—Betamethasone—psoriatic arthritis	0.154	0.343	CbGbCtD
Levonorgestrel—PGR—Dexamethasone—psoriatic arthritis	0.0895	0.2	CbGbCtD
Levonorgestrel—CYP19A1—Betamethasone—psoriatic arthritis	0.0866	0.193	CbGbCtD
Levonorgestrel—Danazol—Prednisone—psoriatic arthritis	0.0622	0.133	CrCrCtD
Levonorgestrel—CYP19A1—Dexamethasone—psoriatic arthritis	0.0503	0.112	CbGbCtD
Levonorgestrel—Progesterone—Prednisolone—psoriatic arthritis	0.0445	0.0953	CrCrCtD
Levonorgestrel—Methyltestosterone—Prednisone—psoriatic arthritis	0.0444	0.0952	CrCrCtD
Levonorgestrel—Methyltestosterone—Prednisolone—psoriatic arthritis	0.0434	0.0929	CrCrCtD
Levonorgestrel—Hydrocortisone—Methylprednisolone—psoriatic arthritis	0.0407	0.0873	CrCrCtD
Levonorgestrel—Hydrocortisone—Dexamethasone—psoriatic arthritis	0.0401	0.0859	CrCrCtD
Levonorgestrel—Hydrocortisone—Betamethasone—psoriatic arthritis	0.0401	0.0859	CrCrCtD
Levonorgestrel—Hydrocortisone—Triamcinolone—psoriatic arthritis	0.0392	0.0839	CrCrCtD
Levonorgestrel—Testosterone—Prednisolone—psoriatic arthritis	0.0386	0.0828	CrCrCtD
Levonorgestrel—Hydrocortisone—Prednisone—psoriatic arthritis	0.0372	0.0797	CrCrCtD
Levonorgestrel—Hydrocortisone—Prednisolone—psoriatic arthritis	0.0363	0.0777	CrCrCtD
Levonorgestrel—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0169	0.0376	CbGbCtD
Levonorgestrel—CYP3A4—Triamcinolone—psoriatic arthritis	0.0128	0.0285	CbGbCtD
Levonorgestrel—CYP3A4—Betamethasone—psoriatic arthritis	0.011	0.0245	CbGbCtD
Levonorgestrel—CYP3A4—Prednisolone—psoriatic arthritis	0.0108	0.0241	CbGbCtD
Levonorgestrel—CYP3A4—Prednisone—psoriatic arthritis	0.0102	0.0228	CbGbCtD
Levonorgestrel—CYP3A4—Dexamethasone—psoriatic arthritis	0.00638	0.0142	CbGbCtD
Levonorgestrel—Arrhythmia—Betamethasone—psoriatic arthritis	0.000144	0.00169	CcSEcCtD
Levonorgestrel—Alopecia—Dexamethasone—psoriatic arthritis	0.000142	0.00167	CcSEcCtD
Levonorgestrel—Alopecia—Betamethasone—psoriatic arthritis	0.000142	0.00167	CcSEcCtD
Levonorgestrel—Discomfort—Prednisolone—psoriatic arthritis	0.000141	0.00166	CcSEcCtD
Levonorgestrel—Angioedema—Triamcinolone—psoriatic arthritis	0.000141	0.00166	CcSEcCtD
Levonorgestrel—Haemoglobin—Prednisone—psoriatic arthritis	0.000141	0.00166	CcSEcCtD
Levonorgestrel—Angioedema—Methylprednisolone—psoriatic arthritis	0.000141	0.00166	CcSEcCtD
Levonorgestrel—Haemorrhage—Prednisone—psoriatic arthritis	0.00014	0.00165	CcSEcCtD
Levonorgestrel—Erythema—Dexamethasone—psoriatic arthritis	0.00014	0.00165	CcSEcCtD
Levonorgestrel—Erythema—Betamethasone—psoriatic arthritis	0.00014	0.00165	CcSEcCtD
Levonorgestrel—Vertigo—Triamcinolone—psoriatic arthritis	0.000139	0.00163	CcSEcCtD
Levonorgestrel—Syncope—Triamcinolone—psoriatic arthritis	0.000139	0.00163	CcSEcCtD
Levonorgestrel—Vertigo—Methylprednisolone—psoriatic arthritis	0.000139	0.00163	CcSEcCtD
Levonorgestrel—Syncope—Methylprednisolone—psoriatic arthritis	0.000138	0.00162	CcSEcCtD
Levonorgestrel—Connective tissue disorder—Prednisone—psoriatic arthritis	0.000138	0.00162	CcSEcCtD
Levonorgestrel—Oedema—Prednisolone—psoriatic arthritis	0.000137	0.00161	CcSEcCtD
Levonorgestrel—Dysuria—Methotrexate—psoriatic arthritis	0.000137	0.00161	CcSEcCtD
Levonorgestrel—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.000136	0.0016	CcSEcCtD
Levonorgestrel—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.000136	0.0016	CcSEcCtD
Levonorgestrel—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.000136	0.00159	CcSEcCtD
Levonorgestrel—Shock—Prednisolone—psoriatic arthritis	0.000135	0.00159	CcSEcCtD
Levonorgestrel—Cough—Triamcinolone—psoriatic arthritis	0.000135	0.00158	CcSEcCtD
Levonorgestrel—Hypertension—Triamcinolone—psoriatic arthritis	0.000133	0.00157	CcSEcCtD
Levonorgestrel—Hypertension—Methylprednisolone—psoriatic arthritis	0.000133	0.00156	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000133	0.00156	CcSEcCtD
Levonorgestrel—Myalgia—Triamcinolone—psoriatic arthritis	0.000132	0.00155	CcSEcCtD
Levonorgestrel—Pneumonia—Methotrexate—psoriatic arthritis	0.000131	0.00154	CcSEcCtD
Levonorgestrel—Myalgia—Methylprednisolone—psoriatic arthritis	0.000131	0.00154	CcSEcCtD
Levonorgestrel—Eye disorder—Prednisone—psoriatic arthritis	0.000131	0.00154	CcSEcCtD
Levonorgestrel—Anxiety—Methylprednisolone—psoriatic arthritis	0.000131	0.00154	CcSEcCtD
Levonorgestrel—Infestation NOS—Methotrexate—psoriatic arthritis	0.000131	0.00153	CcSEcCtD
Levonorgestrel—Infestation—Methotrexate—psoriatic arthritis	0.000131	0.00153	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00013	0.00153	CcSEcCtD
Levonorgestrel—Depression—Methotrexate—psoriatic arthritis	0.00013	0.00153	CcSEcCtD
Levonorgestrel—Discomfort—Triamcinolone—psoriatic arthritis	0.00013	0.00153	CcSEcCtD
Levonorgestrel—Discomfort—Methylprednisolone—psoriatic arthritis	0.00013	0.00152	CcSEcCtD
Levonorgestrel—Angioedema—Dexamethasone—psoriatic arthritis	0.000128	0.00151	CcSEcCtD
Levonorgestrel—Angioedema—Betamethasone—psoriatic arthritis	0.000128	0.00151	CcSEcCtD
Levonorgestrel—Immune system disorder—Prednisone—psoriatic arthritis	0.000127	0.00149	CcSEcCtD
Levonorgestrel—Oedema—Triamcinolone—psoriatic arthritis	0.000126	0.00148	CcSEcCtD
Levonorgestrel—Vertigo—Betamethasone—psoriatic arthritis	0.000126	0.00148	CcSEcCtD
Levonorgestrel—Vertigo—Dexamethasone—psoriatic arthritis	0.000126	0.00148	CcSEcCtD
Levonorgestrel—Syncope—Betamethasone—psoriatic arthritis	0.000126	0.00148	CcSEcCtD
Levonorgestrel—Syncope—Dexamethasone—psoriatic arthritis	0.000126	0.00148	CcSEcCtD
Levonorgestrel—Arrhythmia—Prednisone—psoriatic arthritis	0.000125	0.00147	CcSEcCtD
Levonorgestrel—Infection—Triamcinolone—psoriatic arthritis	0.000125	0.00147	CcSEcCtD
Levonorgestrel—Infection—Methylprednisolone—psoriatic arthritis	0.000125	0.00147	CcSEcCtD
Levonorgestrel—Shock—Triamcinolone—psoriatic arthritis	0.000124	0.00146	CcSEcCtD
Levonorgestrel—Insomnia—Prednisolone—psoriatic arthritis	0.000124	0.00146	CcSEcCtD
Levonorgestrel—Alopecia—Prednisone—psoriatic arthritis	0.000124	0.00146	CcSEcCtD
Levonorgestrel—Shock—Methylprednisolone—psoriatic arthritis	0.000124	0.00145	CcSEcCtD
Levonorgestrel—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000123	0.00145	CcSEcCtD
Levonorgestrel—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000123	0.00145	CcSEcCtD
Levonorgestrel—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000123	0.00145	CcSEcCtD
Levonorgestrel—Mental disorder—Prednisone—psoriatic arthritis	0.000123	0.00144	CcSEcCtD
Levonorgestrel—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000122	0.00144	CcSEcCtD
Levonorgestrel—Erythema—Prednisone—psoriatic arthritis	0.000122	0.00143	CcSEcCtD
Levonorgestrel—Malnutrition—Prednisone—psoriatic arthritis	0.000122	0.00143	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000122	0.00143	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000122	0.00143	CcSEcCtD
Levonorgestrel—Hypertension—Dexamethasone—psoriatic arthritis	0.000121	0.00142	CcSEcCtD
Levonorgestrel—Hypertension—Betamethasone—psoriatic arthritis	0.000121	0.00142	CcSEcCtD
Levonorgestrel—Myalgia—Dexamethasone—psoriatic arthritis	0.000119	0.0014	CcSEcCtD
Levonorgestrel—Myalgia—Betamethasone—psoriatic arthritis	0.000119	0.0014	CcSEcCtD
Levonorgestrel—Anxiety—Betamethasone—psoriatic arthritis	0.000119	0.0014	CcSEcCtD
Levonorgestrel—Anxiety—Dexamethasone—psoriatic arthritis	0.000119	0.0014	CcSEcCtD
Levonorgestrel—Discomfort—Dexamethasone—psoriatic arthritis	0.000118	0.00139	CcSEcCtD
Levonorgestrel—Discomfort—Betamethasone—psoriatic arthritis	0.000118	0.00139	CcSEcCtD
Levonorgestrel—Haemoglobin—Methotrexate—psoriatic arthritis	0.000118	0.00138	CcSEcCtD
Levonorgestrel—Pain—Prednisolone—psoriatic arthritis	0.000117	0.00138	CcSEcCtD
Levonorgestrel—Haemorrhage—Methotrexate—psoriatic arthritis	0.000117	0.00138	CcSEcCtD
Levonorgestrel—Pharyngitis—Methotrexate—psoriatic arthritis	0.000116	0.00137	CcSEcCtD
Levonorgestrel—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000116	0.00136	CcSEcCtD
Levonorgestrel—Urethral disorder—Methotrexate—psoriatic arthritis	0.000115	0.00135	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000115	0.00135	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000115	0.00135	CcSEcCtD
Levonorgestrel—Oedema—Dexamethasone—psoriatic arthritis	0.000114	0.00134	CcSEcCtD
Levonorgestrel—Oedema—Betamethasone—psoriatic arthritis	0.000114	0.00134	CcSEcCtD
Levonorgestrel—Insomnia—Triamcinolone—psoriatic arthritis	0.000114	0.00134	CcSEcCtD
Levonorgestrel—Insomnia—Methylprednisolone—psoriatic arthritis	0.000114	0.00134	CcSEcCtD
Levonorgestrel—Infection—Dexamethasone—psoriatic arthritis	0.000114	0.00134	CcSEcCtD
Levonorgestrel—Infection—Betamethasone—psoriatic arthritis	0.000114	0.00134	CcSEcCtD
Levonorgestrel—Visual impairment—Methotrexate—psoriatic arthritis	0.000113	0.00133	CcSEcCtD
Levonorgestrel—Anaemia—Prednisone—psoriatic arthritis	0.000113	0.00133	CcSEcCtD
Levonorgestrel—Shock—Dexamethasone—psoriatic arthritis	0.000113	0.00132	CcSEcCtD
Levonorgestrel—Shock—Betamethasone—psoriatic arthritis	0.000113	0.00132	CcSEcCtD
Levonorgestrel—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000112	0.00132	CcSEcCtD
Levonorgestrel—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000112	0.00132	CcSEcCtD
Levonorgestrel—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000112	0.00132	CcSEcCtD
Levonorgestrel—Angioedema—Prednisone—psoriatic arthritis	0.000112	0.00131	CcSEcCtD
Levonorgestrel—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000111	0.0013	CcSEcCtD
Levonorgestrel—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000111	0.0013	CcSEcCtD
Levonorgestrel—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000111	0.0013	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000111	0.0013	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000111	0.0013	CcSEcCtD
Levonorgestrel—Vertigo—Prednisone—psoriatic arthritis	0.00011	0.00129	CcSEcCtD
Levonorgestrel—Eye disorder—Methotrexate—psoriatic arthritis	0.00011	0.00129	CcSEcCtD
Levonorgestrel—Syncope—Prednisone—psoriatic arthritis	0.000109	0.00129	CcSEcCtD
Levonorgestrel—Anorexia—Betamethasone—psoriatic arthritis	0.000109	0.00128	CcSEcCtD
Levonorgestrel—Anorexia—Dexamethasone—psoriatic arthritis	0.000109	0.00128	CcSEcCtD
Levonorgestrel—Urticaria—Prednisolone—psoriatic arthritis	0.000109	0.00128	CcSEcCtD
Levonorgestrel—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000109	0.00128	CcSEcCtD
Levonorgestrel—Fatigue—Triamcinolone—psoriatic arthritis	0.000109	0.00128	CcSEcCtD
Levonorgestrel—Fatigue—Methylprednisolone—psoriatic arthritis	0.000108	0.00127	CcSEcCtD
Levonorgestrel—Pain—Triamcinolone—psoriatic arthritis	0.000108	0.00127	CcSEcCtD
Levonorgestrel—Loss of consciousness—Prednisone—psoriatic arthritis	0.000107	0.00126	CcSEcCtD
Levonorgestrel—Immune system disorder—Methotrexate—psoriatic arthritis	0.000106	0.00124	CcSEcCtD
Levonorgestrel—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000106	0.00124	CcSEcCtD
Levonorgestrel—Hypertension—Prednisone—psoriatic arthritis	0.000105	0.00124	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000104	0.00123	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000104	0.00123	CcSEcCtD
Levonorgestrel—Myalgia—Prednisone—psoriatic arthritis	0.000104	0.00122	CcSEcCtD
Levonorgestrel—Anxiety—Prednisone—psoriatic arthritis	0.000104	0.00122	CcSEcCtD
Levonorgestrel—Alopecia—Methotrexate—psoriatic arthritis	0.000104	0.00122	CcSEcCtD
Levonorgestrel—Insomnia—Dexamethasone—psoriatic arthritis	0.000103	0.00122	CcSEcCtD
Levonorgestrel—Insomnia—Betamethasone—psoriatic arthritis	0.000103	0.00122	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000103	0.00121	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000103	0.00121	CcSEcCtD
Levonorgestrel—Discomfort—Prednisone—psoriatic arthritis	0.000103	0.00121	CcSEcCtD
Levonorgestrel—Mental disorder—Methotrexate—psoriatic arthritis	0.000103	0.00121	CcSEcCtD
Levonorgestrel—Erythema—Methotrexate—psoriatic arthritis	0.000102	0.0012	CcSEcCtD
Levonorgestrel—Malnutrition—Methotrexate—psoriatic arthritis	0.000102	0.0012	CcSEcCtD
Levonorgestrel—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000101	0.00119	CcSEcCtD
Levonorgestrel—Dyspepsia—Betamethasone—psoriatic arthritis	0.000101	0.00118	CcSEcCtD
Levonorgestrel—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000101	0.00118	CcSEcCtD
Levonorgestrel—Urticaria—Triamcinolone—psoriatic arthritis	0.0001	0.00118	CcSEcCtD
Levonorgestrel—Urticaria—Methylprednisolone—psoriatic arthritis	0.0001	0.00117	CcSEcCtD
Levonorgestrel—Body temperature increased—Triamcinolone—psoriatic arthritis	9.97e-05	0.00117	CcSEcCtD
Levonorgestrel—Oedema—Prednisone—psoriatic arthritis	9.97e-05	0.00117	CcSEcCtD
Levonorgestrel—Abdominal pain—Methylprednisolone—psoriatic arthritis	9.95e-05	0.00117	CcSEcCtD
Levonorgestrel—Decreased appetite—Betamethasone—psoriatic arthritis	9.95e-05	0.00117	CcSEcCtD
Levonorgestrel—Decreased appetite—Dexamethasone—psoriatic arthritis	9.95e-05	0.00117	CcSEcCtD
Levonorgestrel—Infection—Prednisone—psoriatic arthritis	9.9e-05	0.00116	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	9.88e-05	0.00116	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	9.88e-05	0.00116	CcSEcCtD
Levonorgestrel—Back pain—Methotrexate—psoriatic arthritis	9.87e-05	0.00116	CcSEcCtD
Levonorgestrel—Fatigue—Betamethasone—psoriatic arthritis	9.87e-05	0.00116	CcSEcCtD
Levonorgestrel—Fatigue—Dexamethasone—psoriatic arthritis	9.87e-05	0.00116	CcSEcCtD
Levonorgestrel—Shock—Prednisone—psoriatic arthritis	9.8e-05	0.00115	CcSEcCtD
Levonorgestrel—Pain—Betamethasone—psoriatic arthritis	9.79e-05	0.00115	CcSEcCtD
Levonorgestrel—Pain—Dexamethasone—psoriatic arthritis	9.79e-05	0.00115	CcSEcCtD
Levonorgestrel—Nervous system disorder—Prednisone—psoriatic arthritis	9.77e-05	0.00115	CcSEcCtD
Levonorgestrel—Skin disorder—Prednisone—psoriatic arthritis	9.68e-05	0.00114	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Prednisone—psoriatic arthritis	9.63e-05	0.00113	CcSEcCtD
Levonorgestrel—Anorexia—Prednisone—psoriatic arthritis	9.5e-05	0.00112	CcSEcCtD
Levonorgestrel—Anaemia—Methotrexate—psoriatic arthritis	9.43e-05	0.00111	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Betamethasone—psoriatic arthritis	9.36e-05	0.0011	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	9.36e-05	0.0011	CcSEcCtD
Levonorgestrel—Hypersensitivity—Triamcinolone—psoriatic arthritis	9.29e-05	0.00109	CcSEcCtD
Levonorgestrel—Hypersensitivity—Methylprednisolone—psoriatic arthritis	9.27e-05	0.00109	CcSEcCtD
Levonorgestrel—Vertigo—Methotrexate—psoriatic arthritis	9.17e-05	0.00108	CcSEcCtD
Levonorgestrel—Urticaria—Dexamethasone—psoriatic arthritis	9.09e-05	0.00107	CcSEcCtD
Levonorgestrel—Urticaria—Betamethasone—psoriatic arthritis	9.09e-05	0.00107	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	9.08e-05	0.00107	CcSEcCtD
Levonorgestrel—Dizziness—Prednisolone—psoriatic arthritis	9.07e-05	0.00107	CcSEcCtD
Levonorgestrel—Asthenia—Triamcinolone—psoriatic arthritis	9.05e-05	0.00106	CcSEcCtD
Levonorgestrel—Body temperature increased—Dexamethasone—psoriatic arthritis	9.05e-05	0.00106	CcSEcCtD
Levonorgestrel—Abdominal pain—Dexamethasone—psoriatic arthritis	9.05e-05	0.00106	CcSEcCtD
Levonorgestrel—Body temperature increased—Betamethasone—psoriatic arthritis	9.05e-05	0.00106	CcSEcCtD
Levonorgestrel—Abdominal pain—Betamethasone—psoriatic arthritis	9.05e-05	0.00106	CcSEcCtD
Levonorgestrel—Asthenia—Methylprednisolone—psoriatic arthritis	9.03e-05	0.00106	CcSEcCtD
Levonorgestrel—Insomnia—Prednisone—psoriatic arthritis	9.01e-05	0.00106	CcSEcCtD
Levonorgestrel—Pruritus—Triamcinolone—psoriatic arthritis	8.92e-05	0.00105	CcSEcCtD
Levonorgestrel—Cough—Methotrexate—psoriatic arthritis	8.9e-05	0.00105	CcSEcCtD
Levonorgestrel—Pruritus—Methylprednisolone—psoriatic arthritis	8.9e-05	0.00105	CcSEcCtD
Levonorgestrel—Dyspepsia—Prednisone—psoriatic arthritis	8.77e-05	0.00103	CcSEcCtD
Levonorgestrel—Chest pain—Methotrexate—psoriatic arthritis	8.69e-05	0.00102	CcSEcCtD
Levonorgestrel—Myalgia—Methotrexate—psoriatic arthritis	8.69e-05	0.00102	CcSEcCtD
Levonorgestrel—Decreased appetite—Prednisone—psoriatic arthritis	8.66e-05	0.00102	CcSEcCtD
Levonorgestrel—Rash—Prednisolone—psoriatic arthritis	8.65e-05	0.00102	CcSEcCtD
Levonorgestrel—Dermatitis—Prednisolone—psoriatic arthritis	8.64e-05	0.00102	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	8.63e-05	0.00101	CcSEcCtD
Levonorgestrel—Diarrhoea—Methylprednisolone—psoriatic arthritis	8.61e-05	0.00101	CcSEcCtD
Levonorgestrel—Fatigue—Prednisone—psoriatic arthritis	8.59e-05	0.00101	CcSEcCtD
Levonorgestrel—Headache—Prednisolone—psoriatic arthritis	8.59e-05	0.00101	CcSEcCtD
Levonorgestrel—Discomfort—Methotrexate—psoriatic arthritis	8.58e-05	0.00101	CcSEcCtD
Levonorgestrel—Constipation—Prednisone—psoriatic arthritis	8.52e-05	0.001	CcSEcCtD
Levonorgestrel—Dizziness—Triamcinolone—psoriatic arthritis	8.34e-05	0.00098	CcSEcCtD
Levonorgestrel—Dizziness—Methylprednisolone—psoriatic arthritis	8.32e-05	0.000978	CcSEcCtD
Levonorgestrel—Infection—Methotrexate—psoriatic arthritis	8.27e-05	0.000972	CcSEcCtD
Levonorgestrel—Asthenia—Betamethasone—psoriatic arthritis	8.21e-05	0.000965	CcSEcCtD
Levonorgestrel—Asthenia—Dexamethasone—psoriatic arthritis	8.21e-05	0.000965	CcSEcCtD
Levonorgestrel—Nervous system disorder—Methotrexate—psoriatic arthritis	8.17e-05	0.00096	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Prednisone—psoriatic arthritis	8.15e-05	0.000958	CcSEcCtD
Levonorgestrel—Nausea—Prednisolone—psoriatic arthritis	8.15e-05	0.000957	CcSEcCtD
Levonorgestrel—Pruritus—Betamethasone—psoriatic arthritis	8.1e-05	0.000951	CcSEcCtD
Levonorgestrel—Pruritus—Dexamethasone—psoriatic arthritis	8.1e-05	0.000951	CcSEcCtD
Levonorgestrel—Skin disorder—Methotrexate—psoriatic arthritis	8.09e-05	0.000951	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Methotrexate—psoriatic arthritis	8.05e-05	0.000946	CcSEcCtD
Levonorgestrel—Vomiting—Triamcinolone—psoriatic arthritis	8.02e-05	0.000942	CcSEcCtD
Levonorgestrel—Vomiting—Methylprednisolone—psoriatic arthritis	8e-05	0.00094	CcSEcCtD
Levonorgestrel—Rash—Triamcinolone—psoriatic arthritis	7.95e-05	0.000934	CcSEcCtD
Levonorgestrel—Dermatitis—Triamcinolone—psoriatic arthritis	7.94e-05	0.000934	CcSEcCtD
Levonorgestrel—Anorexia—Methotrexate—psoriatic arthritis	7.94e-05	0.000933	CcSEcCtD
Levonorgestrel—Rash—Methylprednisolone—psoriatic arthritis	7.93e-05	0.000932	CcSEcCtD
Levonorgestrel—Dermatitis—Methylprednisolone—psoriatic arthritis	7.93e-05	0.000932	CcSEcCtD
Levonorgestrel—Urticaria—Prednisone—psoriatic arthritis	7.92e-05	0.00093	CcSEcCtD
Levonorgestrel—Headache—Triamcinolone—psoriatic arthritis	7.9e-05	0.000928	CcSEcCtD
Levonorgestrel—Headache—Methylprednisolone—psoriatic arthritis	7.88e-05	0.000926	CcSEcCtD
Levonorgestrel—Abdominal pain—Prednisone—psoriatic arthritis	7.88e-05	0.000926	CcSEcCtD
Levonorgestrel—Body temperature increased—Prednisone—psoriatic arthritis	7.88e-05	0.000926	CcSEcCtD
Levonorgestrel—Diarrhoea—Betamethasone—psoriatic arthritis	7.83e-05	0.00092	CcSEcCtD
Levonorgestrel—Diarrhoea—Dexamethasone—psoriatic arthritis	7.83e-05	0.00092	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	7.59e-05	0.000892	CcSEcCtD
Levonorgestrel—Dizziness—Dexamethasone—psoriatic arthritis	7.57e-05	0.000889	CcSEcCtD
Levonorgestrel—Dizziness—Betamethasone—psoriatic arthritis	7.57e-05	0.000889	CcSEcCtD
Levonorgestrel—Insomnia—Methotrexate—psoriatic arthritis	7.53e-05	0.000885	CcSEcCtD
Levonorgestrel—Nausea—Triamcinolone—psoriatic arthritis	7.49e-05	0.00088	CcSEcCtD
Levonorgestrel—Nausea—Methylprednisolone—psoriatic arthritis	7.47e-05	0.000878	CcSEcCtD
Levonorgestrel—Dyspnoea—Methotrexate—psoriatic arthritis	7.42e-05	0.000873	CcSEcCtD
Levonorgestrel—Somnolence—Methotrexate—psoriatic arthritis	7.4e-05	0.00087	CcSEcCtD
Levonorgestrel—Hypersensitivity—Prednisone—psoriatic arthritis	7.34e-05	0.000863	CcSEcCtD
Levonorgestrel—Dyspepsia—Methotrexate—psoriatic arthritis	7.33e-05	0.000862	CcSEcCtD
Levonorgestrel—Vomiting—Betamethasone—psoriatic arthritis	7.28e-05	0.000855	CcSEcCtD
Levonorgestrel—Vomiting—Dexamethasone—psoriatic arthritis	7.28e-05	0.000855	CcSEcCtD
Levonorgestrel—Decreased appetite—Methotrexate—psoriatic arthritis	7.24e-05	0.000851	CcSEcCtD
Levonorgestrel—Rash—Betamethasone—psoriatic arthritis	7.21e-05	0.000848	CcSEcCtD
Levonorgestrel—Rash—Dexamethasone—psoriatic arthritis	7.21e-05	0.000848	CcSEcCtD
Levonorgestrel—Dermatitis—Betamethasone—psoriatic arthritis	7.21e-05	0.000847	CcSEcCtD
Levonorgestrel—Dermatitis—Dexamethasone—psoriatic arthritis	7.21e-05	0.000847	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	7.19e-05	0.000845	CcSEcCtD
Levonorgestrel—Fatigue—Methotrexate—psoriatic arthritis	7.18e-05	0.000844	CcSEcCtD
Levonorgestrel—Headache—Betamethasone—psoriatic arthritis	7.17e-05	0.000842	CcSEcCtD
Levonorgestrel—Headache—Dexamethasone—psoriatic arthritis	7.17e-05	0.000842	CcSEcCtD
Levonorgestrel—Asthenia—Prednisone—psoriatic arthritis	7.15e-05	0.00084	CcSEcCtD
Levonorgestrel—Pain—Methotrexate—psoriatic arthritis	7.12e-05	0.000837	CcSEcCtD
Levonorgestrel—Pruritus—Prednisone—psoriatic arthritis	7.05e-05	0.000829	CcSEcCtD
Levonorgestrel—Diarrhoea—Prednisone—psoriatic arthritis	6.82e-05	0.000801	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Methotrexate—psoriatic arthritis	6.81e-05	0.0008	CcSEcCtD
Levonorgestrel—Nausea—Betamethasone—psoriatic arthritis	6.8e-05	0.000799	CcSEcCtD
Levonorgestrel—Nausea—Dexamethasone—psoriatic arthritis	6.8e-05	0.000799	CcSEcCtD
Levonorgestrel—Urticaria—Methotrexate—psoriatic arthritis	6.62e-05	0.000778	CcSEcCtD
Levonorgestrel—Dizziness—Prednisone—psoriatic arthritis	6.59e-05	0.000774	CcSEcCtD
Levonorgestrel—Abdominal pain—Methotrexate—psoriatic arthritis	6.58e-05	0.000774	CcSEcCtD
Levonorgestrel—Body temperature increased—Methotrexate—psoriatic arthritis	6.58e-05	0.000774	CcSEcCtD
Levonorgestrel—Vomiting—Prednisone—psoriatic arthritis	6.34e-05	0.000745	CcSEcCtD
Levonorgestrel—Rash—Prednisone—psoriatic arthritis	6.28e-05	0.000738	CcSEcCtD
Levonorgestrel—Dermatitis—Prednisone—psoriatic arthritis	6.28e-05	0.000738	CcSEcCtD
Levonorgestrel—Headache—Prednisone—psoriatic arthritis	6.24e-05	0.000734	CcSEcCtD
Levonorgestrel—Hypersensitivity—Methotrexate—psoriatic arthritis	6.14e-05	0.000721	CcSEcCtD
Levonorgestrel—Asthenia—Methotrexate—psoriatic arthritis	5.98e-05	0.000702	CcSEcCtD
Levonorgestrel—Nausea—Prednisone—psoriatic arthritis	5.92e-05	0.000696	CcSEcCtD
Levonorgestrel—Pruritus—Methotrexate—psoriatic arthritis	5.89e-05	0.000692	CcSEcCtD
Levonorgestrel—Diarrhoea—Methotrexate—psoriatic arthritis	5.7e-05	0.00067	CcSEcCtD
Levonorgestrel—Dizziness—Methotrexate—psoriatic arthritis	5.51e-05	0.000647	CcSEcCtD
Levonorgestrel—Vomiting—Methotrexate—psoriatic arthritis	5.3e-05	0.000622	CcSEcCtD
Levonorgestrel—Rash—Methotrexate—psoriatic arthritis	5.25e-05	0.000617	CcSEcCtD
Levonorgestrel—Dermatitis—Methotrexate—psoriatic arthritis	5.25e-05	0.000617	CcSEcCtD
Levonorgestrel—Headache—Methotrexate—psoriatic arthritis	5.22e-05	0.000613	CcSEcCtD
Levonorgestrel—Nausea—Methotrexate—psoriatic arthritis	4.95e-05	0.000581	CcSEcCtD
